NFKB1 and atrial fibrillation: Inhibition of the TNF-α/nuclear factor-kappaB (NF-κB)/TGF-β signaling pathway can effectively suppress myocardial fibrosis and cardiac remodeling, thereby attenuating the progression of AF (63).